- Becton Dickinson and Co (NYSE:BDX) issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software.
- Alaris Infusion Central, a standalone software — separate from pumps — provides data from the Alaris pumps, which is not sold in the U.S.
- It allows healthcare providers to monitor infusion data sent from Alaris Plus and Alaris neXus pumps on a computer.
- BD said in the notice that it communicates with customers about cybersecurity vulnerabilities, enabling providers to manage potential risks through awareness and guidance.
- The notice relates to the BD Alaris Infusion Central software, versions 1.1 to 1.3.2.
- BD said the vulnerability received a 7.3 (High) score in the Common Vulnerability Scoring System (CVSS).
- BD said it revised its installation procedure to prevent the vulnerability in future installations. It recommends that users change passwords periodically and ensure physical access controls.
- Price Action: BDX shares are up 0.91% at $244.13 on the last check Friday.
Naked Short-Selling Crackdown: HSBC and BNP Paribas Hit With Fines In South Korea
HSBC Holdings PLC (NYSE: HSBC) and BNP Paribas (OTCQX: BNPQY) were hit with a fine of 26.5 billion won ($20.4 million) by South Korea for naked short-selling.
